Business Segments · Net Sales
Medsurg — Net Sales
Boston Scientific Medsurg — Net Sales increased by 5.1% to $1.81B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from $1.62B to $1.81B. Over 4 years (FY 2021 to FY 2025), Medsurg — Net Sales shows an upward trend with a 16.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase signifies market share growth, successful product launches, or increased demand for MedSurg offerings.
Detailed definition
The total revenue generated by the MedSurg segment from the sale of medical devices and related services, net of returns...
Peer comparison
Standard 'Segment Revenue' or 'Net Sales by Segment' reported by all public companies.
Metric ID:
bsx_segment_medsurg_net_salesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $948.00M | $917.00M | $999.00M | $1.15B | $1.25B | $1.21B | $1.30B | $1.28B | $1.36B | $1.34B | $1.44B | $1.41B | $1.48B | $1.48B | $1.62B | $1.58B | $1.72B | $1.72B | $1.81B |
| QoQ Change | — | -3.3% | +8.9% | +15.4% | +8.2% | -2.8% | +6.9% | -1.3% | +6.3% | -1.4% | +7.5% | -2.0% | +5.0% | -0.3% | +9.5% | -2.6% | +8.8% | +0.3% | +5.1% |
| YoY Change | — | — | — | — | +31.6% | +32.3% | +29.8% | +11.0% | +9.0% | +10.6% | +11.1% | +10.3% | +9.0% | +10.3% | +12.4% | +11.7% | +15.7% | +16.4% | +11.7% |
Range$917.00M – $1.81B
CAGR+15.4%
Avg YoY Growth+15.5%
Median YoY Growth+11.7%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — net sales?
- Boston Scientific (BSX) reported medsurg — net sales of $1.81B in Q4 2025.
- How has Boston Scientific's medsurg — net sales changed year-over-year?
- Boston Scientific's medsurg — net sales increased by 11.7% year-over-year, from $1.62B to $1.81B.
- What is the long-term trend for Boston Scientific's medsurg — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's medsurg — net sales has grown at a 16.3% compound annual growth rate (CAGR), from $3.72B to $6.82B.
- What does medsurg — net sales mean?
- Total revenue earned by the MedSurg business segment.